Orion Portfolio Solutions LLC cut its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Rating) by 0.6% in the 1st quarter, HoldingsChannel reports. The fund owned 55,112 shares of the company’s stock after selling 322 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in VanEck Pharmaceutical ETF were worth $4,396,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Altfest L J & Co. Inc. increased its position in shares of VanEck Pharmaceutical ETF by 72.7% in the first quarter. Altfest L J & Co. Inc. now owns 89,416 shares of the company’s stock valued at $7,132,000 after acquiring an additional 37,634 shares during the period. Phoenix Holdings Ltd. purchased a new position in VanEck Pharmaceutical ETF during the 1st quarter valued at about $7,094,000. Twelve Points Wealth Management LLC bought a new position in VanEck Pharmaceutical ETF during the 4th quarter valued at approximately $4,758,000. Royal Bank of Canada lifted its holdings in VanEck Pharmaceutical ETF by 14.8% in the 1st quarter. Royal Bank of Canada now owns 33,620 shares of the company’s stock worth $2,681,000 after buying an additional 4,333 shares during the period. Finally, Seaview Investment Managers LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 1st quarter worth approximately $1,859,000.
VanEck Pharmaceutical ETF Stock Performance
Shares of VanEck Pharmaceutical ETF stock opened at $70.72 on Thursday. The business has a 50 day moving average of $74.63 and a 200 day moving average of $76.73. VanEck Pharmaceutical ETF has a 52 week low of $69.82 and a 52 week high of $84.27.
VanEck Pharmaceutical ETF Cuts Dividend
- Get a free copy of the StockNews.com research report on VanEck Pharmaceutical ETF (PPH)
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Can Health Drink Maker Celsius Outrun Its Monster Rival?
- Four Cheap Stocks With Interesting Insider Activity
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.